Corbus Pharmaceuticals Holding (CRBP) — Working Capital to Net Assets Ratio
Corbus Pharmaceuticals Holding (CRBP) has a Working Capital to Net Assets ratio of 98.2% as of September 2025. Working capital of $90.51 Million (current assets of $107.57 Million minus current liabilities of $17.06 Million) is measured against net assets of $92.15 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Corbus Pharmaceuticals Holding to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Corbus Pharmaceuticals Holding Working Capital to Net Assets (2012–2024)
This chart shows how Corbus Pharmaceuticals Holding's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 98.2%, reflecting working capital of $90.51 Million against net assets of $92.15 Million USD. Check Corbus Pharmaceuticals Holding tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Corbus Pharmaceuticals Holding (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Corbus Pharmaceuticals Holding from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Corbus Pharmaceuticals Holding worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.1% | $141.16 Million | $142.43 Million | $152.98 Million | $11.82 Million | ▼ -21.8 pp |
| 2023 | 120.9% | $-8.35 Million | $-6.91 Million | $23.55 Million | $31.89 Million | ▼ -23.2 pp |
| 2022 | 144.1% | $47.54 Million | $32.99 Million | $60.18 Million | $12.64 Million | ▲ +23.7 pp |
| 2021 | 120.4% | $83.20 Million | $69.11 Million | $100.20 Million | $17.01 Million | ▼ -12.5 pp |
| 2020 | 132.9% | $60.18 Million | $45.27 Million | $92.07 Million | $31.90 Million | ▲ +79.9 pp |
| 2019 | 53.1% | $3.27 Million | $6.16 Million | $38.15 Million | $34.89 Million | ▼ -42.0 pp |
| 2018 | 95.0% | $26.15 Million | $27.52 Million | $44.24 Million | $18.09 Million | ▼ -4.2 pp |
| 2017 | 99.2% | $57.30 Million | $57.78 Million | $65.50 Million | $8.20 Million | ▲ +3.8 pp |
| 2016 | 95.3% | $8.50 Million | $8.92 Million | $17.40 Million | $8.90 Million | ▼ -5.8 pp |
| 2015 | 101.1% | $9.08 Million | $8.99 Million | $12.71 Million | $3.63 Million | ▲ +2.3 pp |
| 2014 | 98.8% | $5.79 Million | $5.86 Million | $6.53 Million | $738.04K | ▲ +79.6 pp |
| 2013 | 19.3% | $-343.35K | $-1.78 Million | $305.52K | $648.87K | ▲ +154.4 pp |
| 2012 | -135.2% | $268.20 | $-198.38 | $544.98 | $276.78 | — |